AtheroNova Inc. Stock OTC Bulletin Board
Equities
AHRO
US0474382050
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
|
2016 | AtheroNova Operations, Inc. Bankruptcy Case Dismissed | CI |
2015 | First Motion for Exclusivity Period Extension Approved For AtheroNova Operations, Inc. | CI |
Financials (USD)
Sales 2012 | - | Sales 2013 | - | Capitalization | 15.8M |
---|---|---|---|---|---|
Net income 2012 | -2M | Net income 2013 | -7M | EV / Sales 2012 | - |
Net cash position 2012 | 2.38M | Net Debt 2013 | 487K | EV / Sales 2013 | - |
P/E ratio 2012 |
-4.89
x | P/E ratio 2013 |
-1.93
x | Employees | - |
Yield 2012 * |
-
| Yield 2013 |
-
| Free-Float | 100% |
Members of the board | Title | Age | Since |
---|---|---|---|
Johan Spoor
BRD | Director/Board Member | 52 | 12-01-02 |
1st Jan change | Capi. | |
---|---|---|
+23.50% | 45.01B | |
+47.19% | 40.96B | |
-5.16% | 38.62B | |
+36.37% | 32.6B | |
-7.79% | 27.49B | |
+18.06% | 27.17B | |
+47.29% | 14.61B | |
+41.91% | 12.95B | |
-1.02% | 11.36B |
- Stock Market
- Equities
- AHROQ Stock
- AHRO Stock